by Nakita | Jun 11, 2026 | Latest News, Research Opportunities
In this article, we use “lupus” instead of “SLE” (systemic lupus erythematosus). In England and Wales, doctors can use a medicine called obinutuzumab to treat kidney disease caused by lupus. You might know this as lupus nephritis. Research has shown that obinutuzumab...
by Nakita | May 21, 2026 | Research Opportunities
Complete the survey here Why have you been asked? Obinutuzumab is a medicine that has just been approved for the treatment of kidney disease in people with lupus. Michael Robson’s research team are planning a study on the best way to use it. They would like to...
by Nakita | May 21, 2026 | Research Opportunities
From Partner to Caregiver: Identity Change and its Consequences in Autoimmune Disease This research explores how romantic partners of people with flare‑remitting autoimmune diseases, such as lupus, experience the shift from being a partner to becoming a caregiver....
by Nakita | May 21, 2026 | Research Opportunities
BILAG Biologics Register Are you starting treatment with a biologic, biosimilar or other new therapy for your lupus? You could be eligible to join the BILAG Biologics Register (BR) and help them collect important data about the safety and effectiveness of different...
by Nakita | Mar 4, 2026 | Research Opportunities
The ADAPT TrialA team of researchers, patients and clinicians are looking at whether Pilates or Tai Chi online group classes can reduce fatigue and improve quality of life. Location: Online Deadline: Recruitment closes when the study is full. Spaces are limited, so...
by Nakita | Feb 7, 2026 | Research Opportunities
The General Pharmaceutical Council (GPhC) The General Pharmaceutical Council (GPhC) makes sure pharmacy is safe and effective for patients and the public. They are inviting patients, carers, and members of the public to share their views on pharmacy services across...
